Insider Transactions Reported by 9 Insiders of Silence Therapeutics plc

Symbol
SLN on Nasdaq, SLNCF on OTC
Industry
Pharmaceutical Preparations
Location
London, United Kingdom

There are no Buy or Sell transactions made by insiders since 12/15/2024

Silence Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Steven J. Romano EVP and Chief R&D Officer Jan 2, 2025
David Lemus Director Jan 2, 2025
Rhonda Hellums Chief Financial Officer Jan 2, 2025
Michael H. Davidson Director Jan 2, 2025
James Ede-Golightly Director Jan 2, 2025
Iain Ross Director Jan 2, 2025
Craig A. Tooman President and CEO, Director Jan 2, 2025
Richard Ian Griffiths 10%+ Owner Jul 31, 2025
Timothy Mcinerney Director May 5, 2025

Recent Insider Transactions by Companies or Individuals for Silence Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.